You are here

Clinical Trials: Trauma

Each Clinical Trial will open in a new browser window or tab.

Return to Clinical Trials Page

Posted: Tuesday, April 28, 2020 - 12:00
Condition:   Covid-19
Interventions:   Biological: Cell therapy protocol 1;   Biological: Cell therapy protocol 2
Sponsors:   Royan Institute;   Tehran University of Medical Sciences;   Shahid Beheshti University of Medical Sciences
Posted: Wednesday, April 22, 2020 - 12:00
Condition:   Systemic Sclerosis
Interventions:   Procedure: Adipose tissue harvest;   Drug: Autologous ASC;   Drug: Placebo
Sponsor:   University Hospital, Toulouse
Not yet recruiting
Posted: Tuesday, April 21, 2020 - 12:00
Conditions:   Corona Virus Infection;   ARDS;   ARDS, Human;   Acute Respiratory Distress Syndrome
Interventions:   Biological: Umbilical Cord Mesenchymal Stem Cells;   Other: Standard of Care
Sponsor:   Camillo Ricordi
Posted: Wednesday, April 15, 2020 - 12:00
Condition:   Acute Respiratory Distress Syndrome
Intervention:   Biological: UMC119-06
Sponsor:   Meridigen Biotech Co., Ltd.
Not yet recruiting
Posted: Thursday, April 9, 2020 - 12:00
Condition:   COVID-19
Interventions:   Biological: UC-MSCs;   Other: Placebo
Sponsors:   Puren Hospital Affiliated to Wuhan University of Science and Technology;   Shanghai University;   Qingdao Co-orient Watson Biotechnology group co. LTD;   Basic Medical Sciences, Chinese Academy of Medical Sciences
Posted: Thursday, April 2, 2020 - 12:00
Conditions:   COVID-19;   Acute Respiratory Distress Syndrome;   Virus; Pneumonia;   Acute Lung Injury
Intervention:   Biological: CAStem
Sponsors:   Chinese Academy of Sciences;   Beijing YouAn Hospital
Posted: Monday, March 30, 2020 - 12:00
Conditions:   Pulmonary Alveolar Proteinosis;   COPD;   Idiopathic Pulmonary Fibrosis;   Viral Pneumonia;   Coronavirus Infection;   Interstitial Lung Disease
Interventions:   Procedure: Microcannula Harvest Adipose Derived tissue stromal vascular fraction (tSVF);   Device: Centricyte 1000;   Procedure: IV Deployment Of cSVF In Sterile Normal Saline IV Solution;   Drug: Liberase Enzyme (Roche);   Drug: Sterile Normal Saline for Intravenous Use
Sponsors:   Black Tie Medical, Inc.;   Robert W. Alexander, MD
Posted: Wednesday, March 18, 2020 - 12:00
Condition:   Healthy
Interventions:   Biological: Low level of MSCs-Exo;   Biological: High level of MSCs-Exo
Sponsors:   Ruijin Hospital;   Cellular Biomedicine Group Ltd.
Posted: Friday, March 13, 2020 - 12:00
Condition:   Critical Limb Ischemia
Interventions:   Drug: Evolocumab 140mg/mL Injector 1milliliter (mL) Pen x 3 for a monthly dose of 420 mg for 12 months.;   Other: Placebo 1 milliliter (mL) Injector Pen x 3 monthly for 12 months
Sponsors:   Leonardo Clavijo;   Amgen
Posted: Friday, March 6, 2020 - 12:00
Condition:   Alveolar Bone Atrophy
Interventions:   Combination Product: Advanced medicinal Therapy (MSC combined with biomaterial);   Procedure: Autologous bone graft
Sponsors:   University of Bergen;   Université de Nantes;   University of Ulm;   Universidad Complutense de Madrid;   University of Aarhus;   Universitat Internacional de Catalunya;   Assistance Publique - Hôpitaux de Paris;   European Commission